Andrew J. Storaska

Andrew J. Storaska

ID: 1b83c156-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

Patent Thickets and Regulatory Challenges Cited as Major Factors Limiting Price Reductions in the Biologic Drug Space

Biosimilars Law Bulletin · November 11, 2020

The Federal Circuit Affirms District Court Finding that Sandoz Does Not Infringe Amgen’s Protein Purification Patent

Biosimilars Law Bulletin · June 20, 2019

Pfizer Loses Out On Its Follow-On Petition Challenges to Genentech’s anti-HER2 Patents Because It Did Not Follow <i>General Plastics</i> Guidance

Biosimilars Law Bulletin · September 11, 2018

How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline

Biosimilars Law Bulletin · August 2, 2018

U.S. FDA Approves First Biosimilar to Neulasta

Biosimilars Law Bulletin · June 29, 2018

Practice Areas

Health Care and Life Sciences

Intellectual Property

Business and Commercial

Jurisdictions

Washington, D.C.